Susquehanna International Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.05M | Sell |
18,513
-120,697
| -87% | -$7.04M | ﹤0.01% | 7776 |
|
|
2025
Q4 | $8.27M | Sell |
139,210
-42,784
| -24% | -$2.33M | ﹤0.01% | 3305 |
|
|
2025
Q3 | $9.86M | Buy |
181,994
+166,116
| +1,046% | +$9.5M | ﹤0.01% | 3058 |
|
|
2025
Q2 | $873K | Sell |
15,878
-75,602
| -83% | -$4.45M | ﹤0.01% | 7780 |
|
|
2025
Q1 | $6.47M | Buy |
91,480
+506
| +0.6% | +$34K | ﹤0.01% | 3184 |
|
|
2024
Q4 | $5.98M | Sell |
90,974
-19,149
| -17% | -$1.28M | ﹤0.01% | 3337 |
|
|
2024
Q3 | $7.74M | Buy |
110,123
+73,045
| +197% | +$6.11M | ﹤0.01% | 2962 |
|
|
2024
Q2 | $3.05M | Sell |
37,078
-639,608
| -95% | -$53.2M | ﹤0.01% | 4278 |
|
|
2024
Q1 | $59.1M | Buy |
676,686
+417,128
| +161% | +$37.3M | 0.01% | 923 |
|
|
2023
Q4 | $25M | Sell |
259,558
-55,190
| -18% | -$4.88M | ﹤0.01% | 1582 |
|
|
2023
Q3 | $27.8M | Sell |
314,748
-122,730
| -28% | -$10.9M | 0.01% | 1449 |
|
|
2023
Q2 | $37.9M | Buy |
437,478
+89,563
| +26% | +$8.43M | 0.01% | 1183 |
|
|
2023
Q1 | $33.8M | Buy |
347,915
+155,060
| +80% | +$16.1M | 0.01% | 1227 |
|
|
2022
Q4 | $20M | Sell |
192,855
-80,282
| -29% | -$7.54M | 0.01% | 1523 |
|
|
2022
Q3 | $23.2M | Buy |
273,137
+264,455
| +3,046% | +$23.5M | 0.01% | 1302 |
|
|
2022
Q2 | $720K | Sell |
8,682
-87,429
| -91% | -$6.96M | ﹤0.01% | 7348 |
|
|
2022
Q1 | $7.41M | Sell |
96,111
-24,194
| -20% | -$2.02M | ﹤0.01% | 2981 |
|
|
2021
Q4 | $10.6M | Sell |
120,305
-102,090
| -46% | -$8.42M | ﹤0.01% | 2623 |
|
|
2021
Q3 | $17.2M | Buy |
222,395
+96,560
| +77% | +$7.62M | ﹤0.01% | 2147 |
|
|
2021
Q2 | $10.5M | Sell |
125,835
-296,140
| -70% | -$23.5M | ﹤0.01% | 2848 |
|
|
2021
Q1 | $31.9M | Buy |
421,975
+57,791
| +16% | +$4.72M | 0.01% | 1436 |
|
|
2020
Q4 | $31.9M | Buy |
364,184
+158,217
| +77% | +$12.5M | 0.01% | 1322 |
|
|
2020
Q3 | $15.7M | Buy |
205,967
+45,096
| +28% | +$4.56M | ﹤0.01% | 1728 |
|
|
2020
Q2 | $19.8M | Sell |
160,871
-51,873
| -24% | -$5.16M | ﹤0.01% | 1432 |
|
|
2020
Q1 | $18M | Sell |
212,744
-383,070
| -64% | -$33M | 0.01% | 1250 |
|
|
2019
Q4 | $50.4M | Buy |
595,814
+144,939
| +32% | +$10.9M | 0.01% | 799 |
|
|
2019
Q3 | $30.4M | Buy |
450,875
+309,777
| +220% | +$23.9M | 0.01% | 1039 |
|
|
2019
Q2 | $12.1M | Buy |
+141,098
| New | +$12.1M | ﹤0.01% | 1712 |
|
|
2018
Q3 | – | Sell |
-193,029
| Closed | -$19.3M | – | 9225 |
|
|
2018
Q2 | $18.2M | Buy |
193,029
+138,975
| +257% | +$12.2M | 0.01% | 1377 |
|
|
2018
Q1 | $4.38M | Sell |
54,054
-148,539
| -73% | -$12.7M | ﹤0.01% | 2707 |
|
|
2017
Q4 | $18.1M | Buy |
202,593
+186,042
| +1,124% | +$16.2M | 0.01% | 1327 |
|
|
2017
Q3 | $1.54M | Sell |
16,551
-102,277
| -86% | -$9.04M | ﹤0.01% | 4403 |
|
|
2017
Q2 | $10.8M | Buy |
118,828
+17,288
| +17% | +$1.57M | ﹤0.01% | 1636 |
|
|
2017
Q1 | $8.91M | Sell |
101,540
-223,449
| -69% | -$19.9M | ﹤0.01% | 1730 |
|
|
2016
Q4 | $26.9M | Sell |
324,989
-37,642
| -10% | -$3.24M | 0.01% | 853 |
|
|
2016
Q3 | $33.6M | Buy |
362,631
+99,211
| +38% | +$9.34M | 0.02% | 705 |
|
|
2016
Q2 | $20.5M | Buy |
263,420
+90,022
| +52% | +$7.65M | 0.01% | 959 |
|
|
2016
Q1 | $14.3M | Buy |
173,398
+74,518
| +75% | +$6.06M | 0.01% | 1237 |
|
|
2015
Q4 | $10.4M | Buy |
98,880
+51,538
| +109% | +$5.38M | ﹤0.01% | 1710 |
|
|
2015
Q3 | $4.99M | Sell |
47,342
-177,574
| -79% | -$23.7M | ﹤0.01% | 2681 |
|
|
2015
Q2 | $30.8M | Buy |
224,916
+67,316
| +43% | +$8.34M | 0.01% | 979 |
|
|
2015
Q1 | $19.6M | Buy |
157,600
+116,980
| +288% | +$12.4M | 0.01% | 1248 |
|
|
2014
Q4 | $3.67M | Buy |
40,620
+26,292
| +184% | +$2.19M | ﹤0.01% | 3372 |
|
|
2014
Q3 | $1.03M | Sell |
14,328
-52,189
| -78% | -$3.43M | ﹤0.01% | 5853 |
|
|
2014
Q2 | $4.14M | Buy |
66,517
+27,690
| +71% | +$1.67M | ﹤0.01% | 3379 |
|
|
2014
Q1 | $2.65M | Sell |
38,827
-71,911
| -65% | -$5.3M | ﹤0.01% | 3837 |
|
|
2013
Q4 | $7.78M | Sell |
110,738
-64,145
| -37% | -$4.36M | ﹤0.01% | 2362 |
|
|
2013
Q3 | $12.6M | Sell |
174,883
-31,008
| -15% | -$2.06M | 0.01% | 1641 |
|
|
2013
Q2 | $11.5M | Buy |
+205,891
| New | +$12.8M | 0.01% | 1634 |
|
Other funds holding BMRN
VCM
VPM
Susquehanna International Group's BMRN Position: Q1 2026 in Review
Susquehanna International Group reduced its BioMarin Pharmaceuticals (BMRN) stake by 87% in Q1 2026, selling an estimated $7.04M and leaving 18,513 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #7776.
Susquehanna International Group first reported a position in BMRN in Q2 2013 and has held it in 49 quarters since. The position peaked at $59.1M in Q1 2024. 556 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Susquehanna International Group held 18,513 shares of BioMarin Pharmaceuticals worth $1.05M as of Q1 2026.
- Susquehanna International Group sold 120,697 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $7.04M.
- BioMarin Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7776 holding.
- Susquehanna International Group first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's BioMarin Pharmaceuticals position peaked at $59.1M in Q1 2024.
- 556 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.